Iotalamic acid
Chemical compound
- US DailyMed: Iothalamate
administration
- V08AA04 (WHO)
- US: ℞-only[1][2][3]
- 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid
- 2276-90-6
- 3737
- DB09133
- 3606
- 16CHD79MIX
- D01258
- CHEBI:31713
- ChEMBL1201300
- DTXSID5023164
- Interactive image
- CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I
- InChI=1S/C11H9I3N2O4/c1-3(17)16-9-7(13)4(10(18)15-2)6(12)5(8(9)14)11(19)20/h1-2H3,(H,15,18)(H,16,17)(H,19,20)
- Key:UXIGWFXRQKWHHA-UHFFFAOYSA-N
Iotalamic acid, sold under the brand name Conray, is an iodine-containing radiocontrast agent. It is available in form of its salts, sodium iotalamate and meglumine iotalamate. It can be given intravenously or intravesically (into the urinary bladder).[1]
A radioactive formulation is also available as sodium iothalamate I-125 injection (brand name Glofil-125). It is indicated for evaluation of glomerular filtration in the diagnosis or monitoring of people with kidney disease.[2]
References
- ^ a b c "Conray- iothalamate meglumine injection". DailyMed. 1 January 2021. Retrieved 23 February 2022.
- ^ a b "Glofil-125- sodium iothalamate i-125 injection injection, solution". DailyMed. 9 December 2019. Retrieved 23 February 2022.
- ^ "Cysto-Conray II- iothalamate meglumine injection". DailyMed. 31 December 2020. Retrieved 23 February 2022.
External links
- "Iothalamate meglumine". Drug Information Portal. U.S. National Library of Medicine.
- "Iothalamate sodium". Drug Information Portal. U.S. National Library of Medicine.
- v
- t
- e
Iodinated, Water soluble |
| ||||||
---|---|---|---|---|---|---|---|
Iodinated, Water insoluble |
| ||||||
Non-iodinated |
Paramagnetic | |
---|---|
Superparamagnetic |
|
Other |
- Microspheres of human albumin
- Microparticles of galactose
- Perflenapent
- Microspheres of phospholipids
- Sulfur hexafluoride
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e